ArticleEJNMMI research2025
Multinomial logistic regression algorithm for the classification of patients with parkinsonisms.
Article in EJNMMI research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Review of FDG-PET in Progressive Supranuclear Palsy and Corticobasal Syndrome.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAccurate differential diagnosis of neurodegenerative parkinsonisms is challenging due to overlapping early symptoms and high rates of misdiagnosis. To improve the diagnostic accuracy, we developed an integrated classification algorithm using multinomial logistic regression and Scaled Subprofile Model/Principal Component Analysis (SSM/PCA) applied to
resultsThe Area Under the Curve (AUC) values were the highest for progressive supranuclear palsy (PSP) (AUC = 0.95), followed by Parkinson's disease (PD) (AUC = 0.93) and multiple system atrophy (MSA) (AUC = 0.90). When classifying the patients based on their calculated probability for each group, the desired tradeoff between sensitivity and specificity had to be selected. With a 99% probability threshold for classification into a disease group, 82% of PD patients, 29% of MSA patients, and 77% of PSP patients were correctly identified. Only 5% of PD, 6% of MSA and 6% of PSP patients were misclassified, whereas the remaining patients (13% of PD, 65% of MSA and 18% of PSP) are undetermined by our classification algorithm.
conclusionsCompared to existing algorithms, this approach offers comparable accuracy and reliability in diagnosing PD, MSA, and PSP with no need of healthy control images. It can also distinguish between multiple types of parkinsonisms simultaneously and offers the flexibility to easily accommodate new groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.